← Leaderboards
Miguel Valderrabano
Methodist Hospital Research Institute
$7,764,932
Attributed
$8,961,388
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,961,388 · 6
By mechanism
R01$5,969,604 · 2
R33$1,382,174 · 1
R21$871,351 · 2
R61$738,259 · 1
Top collaborators
- Francisco Altamirano3 shared
Most similar at Methodist Hospital Research Institute
Same institution · by research overlap
- Francisco Altamirano$2,811,457
- Dipan J. Shah$2,960,139
Others in their field
Top investigators on “Veins”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Paul M. Ridker · Brigham And Women'S Hospital$35,038,577
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Jennifer Katherine Sun · Jaeb Center For Health Research, Inc.$20,075,374
- Adam R Glassman · Jaeb Center For Health Research, Inc.$20,075,374
- Daniel F Martin · Jaeb Center For Health Research, Inc.$20,075,374
Research focus
VeinsNerveAblationCardiac AblationCoronary Sinus StructureProceduresCardiacRouteTissuesAreaArrhythmiaRecurrenceSafetyAtrial FibrillationSuccessHeart AtriumEthanolLeftAdultInfusion ProceduresDenervationGangliaHeartAnatomy
Grant awards (15)
Cardiac Autonomic Activation In Atrial Fibrillation Triggers And Substrate$802,991
R01 · FY2025 · HL · contact PI
VENOUS ETHANOL ABLATION IN ISCHEMIC VENTRICULAR TACHYCARDIA- VELVET TRIAL$691,087
R33 · FY2025 · HL · contact PI
Cardiac Autonomic Activation In Atrial Fibrillation Triggers And Substrate$786,931
R01 · FY2024 · HL · contact PI
VENOUS ETHANOL ABLATION IN ISCHEMIC VENTRICULAR TACHYCARDIA- VELVET TRIAL$691,087
R33 · FY2024 · HL · contact PI
Cardiac Autonomic Activation In Atrial Fibrillation Triggers And Substrate$802,991
R01 · FY2023 · HL · contact PI
VENOUS ETHANOL ABLATION IN ISCHEMIC VENTRICULAR TACHYCARDIA- VELVET TRIAL$738,259
R61 · FY2023 · HL · contact PI
Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation$600,284
R01 · FY2017 · HL · contact PI
Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation$732,265
R01 · FY2016 · HL · contact PI
Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation$735,081
R01 · FY2015 · HL · contact PI
Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation$751,801
R01 · FY2014 · HL · contact PI
Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation$757,260
R01 · FY2013 · HL · contact PI
Vein of Marshall as a therapeutic agent in the treatment of atrial fibrillation$192,500
R21 · FY2011 · HL · contact PI
Vein of Marshall as a therapeutic agent in the treatment of atrial fibrillation$231,000
R21 · FY2010 · HL · contact PI
Nanosecond megavolt pulse technology for cardiac stimulation and defibrillation$202,792
R21 · FY2007 · HL · contact PI
Nanosecond megavolt pulse technology for cardiac stimulation and defibrillation$245,059
R21 · FY2006 · HL · contact PI